Champions Oncology, Inc.
corporate_fare Company Profile
Champions Oncology, Inc. (NASDAQ:CSBR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 9 items for CSBR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-10, rated 7/10. Across its 9 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for CSBR spans 8-K, 10-K, 10-Q.
Recent high-impact activity:
- Champions Oncology Q1 Revenue Up 8.8%, Margin Jumps to 51%, Adjusted EBITDA Soars
- Champions Oncology Q1 Revenue Rises 8.8% on Research Services Strength
- Champions Oncology Swings to a Loss as Cash Burn Accelerates and Runway Narrows
- Champions Oncology Posts Record $59.4M Annual Revenue and Fourth Consecutive Quarter of Positive Adjusted EBITDA
- Champions Oncology Q4 Revenue Jumps 12% to $13.8M, Margins Improve on Cost Cuts
Financial Snapshot
Short Interest & Short Volume
8.55 days to coverFINRA reported short interest of 72,290 shares in CSBR as of the October 30, 2026 settlement, a 6.9% decrease from the prior period — about 8.6 days to cover at its recent average daily volume. On November 20, 2026, 33.8% of CSBR volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.